Literature DB >> 24503355

Epidemiology of gastroesophageal reflux disease.

Joel H Rubenstein1, Joan W Chen2.   

Abstract

The prevalence of gastroesophageal reflux disease (GERD) symptoms increased approximately 50% until the mid-1990s, when it plateaued. The incidence of complications related to GERD including hospitalization, esophageal strictures, esophageal adenocarcinoma, and mortality also increased during that time period, but the increase in esophageal adenocarcinoma has since slowed, and the incidence of strictures has decreased since the mid-1990s. GERD is responsible for the greatest direct costs in the United States of any gastrointestinal disease, and most of those expenditures are for pharmacotherapy. Risk factors for GERD include obesity, poor diet, lack of physical activity, consumption of tobacco and alcohol, and respiratory diseases. Published by Elsevier Inc.

Entities:  

Keywords:  Cost; Esophageal neoplasms; Esophageal strictures; Incidence; Prevalence; Risk factors

Mesh:

Year:  2013        PMID: 24503355     DOI: 10.1016/j.gtc.2013.11.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  30 in total

1.  Clinical significance of ALDH1 combined with DAPI expression in patients with esophageal carcinoma.

Authors:  Hong Chen; Zhi-Qiang Zhang; Bin Zhao; Wen-Long Ning; Xue-Yan Wang; Fei Zhou
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

2.  Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.

Authors:  George Triadafilopoulos; Thomas Zikos; Kirsten Regalia; Irene Sonu; Nielsen Q Fernandez-Becker; Linda Nguyen; Monica Christine R Nandwani; John O Clarke
Journal:  Dig Dis Sci       Date:  2018-06-29       Impact factor: 3.199

3.  Excess Alcohol Consumption: A Potential Mechanism Behind the Association Between Small Intestinal Bacterial Overgrowth and Coronary Artery Disease.

Authors:  Zhiqing He; Ru Ding; Feng Wu; Zonggui Wu; Chun Liang
Journal:  Dig Dis Sci       Date:  2018-10-26       Impact factor: 3.199

Review 4.  Integrative Medicine for Gastrointestinal Disease.

Authors:  Michelle L Dossett; Ezra M Cohen; Jonah Cohen
Journal:  Prim Care       Date:  2017-06       Impact factor: 2.907

Review 5.  Surgical Treatment of Extraesophageal Manifestations of Gastroesophageal Reflux Disease.

Authors:  Feroze Sidwa; Alessandra L Moore; Elaine Alligood; P Marco Fisichella
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

6.  Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel.

Authors:  Andrew J Gawron; Reginald Bell; Barham K Abu Dayyeh; F P Buckley; Kenneth Chang; Christy M Dunst; Steven A Edmundowicz; Blair Jobe; John C Lipham; Dan Lister; Marcia Irene Canto; Michael S Smith; Anthony A Starpoli; George Triadafilopoulos; Thomas J Watson; Erik Wilson; John E Pandolfino; Alexander Kaizer; Zoe Van De Voorde; Rena Yadlapati
Journal:  Gastrointest Endosc       Date:  2020-01-31       Impact factor: 9.427

Review 7.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

8.  Objective Evaluation of Gastroesophageal Reflux Disease in Patients with Paroxysmal Atrial Fibrillation.

Authors:  Enia Lucia Coutinho; Fernando A M Herbella; Carlos Alexandre Volponi Lovato; Marco G Patti; Francisco Schlottmann; Angelo Amato Vincenzo de Paola
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

9.  Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy.

Authors:  Salva Balbale; Andrew Gawron; Sherri L LaVela
Journal:  Patient Exp J       Date:  2018

10.  BRAVO esophageal pH monitoring: more cost-effective than empiric medical therapy for suspected gastroesophageal reflux.

Authors:  Cheguevara Afaneh; Veronica Zoghbi; Brendan M Finnerty; Anna Aronova; David Kleiman; Thomas Ciecierega; Carl Crawford; Thomas J Fahey; Rasa Zarnegar
Journal:  Surg Endosc       Date:  2015-11-04       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.